Washington, DC: The new drug application for the antibiotic, Ketek, was rejected twice, in 2001 and 2003, before FDA management approved the drug on April 1, 2004, based on fraudulent studies, and over the objections of the agency’s own scientists. 

The approval of Ketek, marketed by Sanofi-Aventis, follows a pattern that has emerged since …

Read more: FDA Hounded Over Ketek Scandal or FDA Hounded Over Ketek Scandal